Register an account to search through 14,000+ stocks! 

ABT – Abbott Laboratories

✔ COMPLIANT

★★★

Company Profile

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.

Business

PASS

Abbott Laboratories has cleared the Business screen. Its business activity is compliant with the Shariah standard and its impure income is less than 5%. If you find this result mistaken or questionable, let us know in the comments.

Problematic Revenues N/A
Interest & Investment Income%
0.16%
Total 0.16%

Fundamentals

Market cap $219922000000
Assets
$72548000000
ROA
10.17
Div./Share
$1.44

Financials

PASS

The financials pass all the three standards we check against.

Debt/A Cash/A (AR+C)/A
25.84%
9.85%
19.33%
< 33%
< 33%
< 50%
P
P
P
Debt/MC Cash/MC
8.52%
3.25%
< 30%
< 30%
P
P
Debt/24MC Cash/24MC AR/24MC
9.98%
9.85%
3.66%
< 33%
< 33%
< 33%
P
P
P

Note: A = Assets | AR = Accounts Receivables | MC = Market cap | 24MC = 24 month avg. Market cap

✔ FTSE ✔ AAOIFI ✔ DJIM

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Responses